Karl Egerer

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Clinical and serological evaluation of a novel CENP-A peptide based ELISA
    Michael Mahler
    Dr Fooke Laboratorien, Mainstrasse 85, 41469 Neuss, Germany
    Arthritis Res Ther 12:R99. 2010
  2. ncbi Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests
    Karl Egerer
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany
    Arthritis Res Ther 12:R40. 2010
  3. ncbi Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay
    Karl Egerer
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Augustenburger Platz 01, 13555 Berlin, Germany
    Arthritis Res Ther 13:R118. 2011
  4. ncbi The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens
    Karl Egerer
    Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin, Germany
    Dtsch Arztebl Int 106:159-63. 2009
  5. ncbi Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort
    Katharina Hanke
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, Berlin 10117, Germany
    Arthritis Res Ther 11:R28. 2009
  6. ncbi Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay
    Franziska Renger
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany
    Arthritis Res Ther 12:R120. 2010
  7. ncbi Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus
    Robert Biesen
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, Berlin D 10117, Germany
    Arthritis Res Ther 13:R26. 2011
  8. ncbi Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus
    Fidan Barkhudarova
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, Berlin D 10117, Germany
    Arthritis Res Ther 13:R20. 2011
  9. ncbi Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28
    Michael Brychcy
    Department of Rheumatology and Clinical Immunology, , Schumannstrasse 20/21, D-10117 Berlin, Germany
    Arthritis Rheum 54:2175-83. 2006
  10. ncbi Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy
    Antje Voigt
    Medizinische Klinik für Kardiologie und Angiologie, Charite Universitatsmedizin Berlin, Campus Mitte, Chariteplatz 1, Berlin, Germany
    Basic Res Cardiol 105:557-67. 2010

Collaborators

Detail Information

Publications16

  1. ncbi Clinical and serological evaluation of a novel CENP-A peptide based ELISA
    Michael Mahler
    Dr Fooke Laboratorien, Mainstrasse 85, 41469 Neuss, Germany
    Arthritis Res Ther 12:R99. 2010
    ..Historically, ACA were detected by indirect immunofluorescence (IIF) on HEp-2 cells and confirmed by immunoassays using recombinant CENP-B. The objective of this study was to evaluate a novel CENP-A peptide ELISA...
  2. ncbi Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests
    Karl Egerer
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany
    Arthritis Res Ther 12:R40. 2010
    ..Comparing automated and visual interpretation, the usefulness for routine laboratory diagnostics was investigated...
  3. ncbi Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay
    Karl Egerer
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Augustenburger Platz 01, 13555 Berlin, Germany
    Arthritis Res Ther 13:R118. 2011
    ..Diagnosis of antiphospholipid syndrome (APS) still remains a laboratory challenge due to the great diversity of antiphospholipid antibodies (aPL) and their significance regarding APS-diagnostic criteria...
  4. ncbi The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens
    Karl Egerer
    Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin, Germany
    Dtsch Arztebl Int 106:159-63. 2009
    ..Recommendations are also given for differential diagnosis and sequential testing in rheumatoid arthritis, with a view towards improving early diagnosis, so that irreparable joint damage can be avoided...
  5. ncbi Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort
    Katharina Hanke
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, Berlin 10117, Germany
    Arthritis Res Ther 11:R28. 2009
    ..In the present study, the detection of anti-topoisomerase I (anti-topo I) autoantibodies was evaluated for diagnosis and risk assessment of systemic sclerosis (SSc) patients in a well characterized large monocentric cohort...
  6. ncbi Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay
    Franziska Renger
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany
    Arthritis Res Ther 12:R120. 2010
    ..The aim of this study was to develop and evaluate a point of care test (POCT) for detection of anti-MCV antibodies immediately at the first visit or at the bed side...
  7. ncbi Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus
    Robert Biesen
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, Berlin D 10117, Germany
    Arthritis Res Ther 13:R26. 2011
    ....
  8. ncbi Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus
    Fidan Barkhudarova
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Chariteplatz 1, Berlin D 10117, Germany
    Arthritis Res Ther 13:R20. 2011
    ..In this study, we sought to determine the diagnostic value and clinical laboratory associations of autoantibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in systemic lupus erythematosus (SLE)...
  9. ncbi Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28
    Michael Brychcy
    Department of Rheumatology and Clinical Immunology, , Schumannstrasse 20/21, D-10117 Berlin, Germany
    Arthritis Rheum 54:2175-83. 2006
    ..Antibody targeting of the interaction between 20S proteasome and PA28 represents a novel mechanism of proteasome inhibition...
  10. ncbi Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy
    Antje Voigt
    Medizinische Klinik für Kardiologie und Angiologie, Charite Universitatsmedizin Berlin, Campus Mitte, Chariteplatz 1, Berlin, Germany
    Basic Res Cardiol 105:557-67. 2010
    ..In conclusion, our data argue against a direct impact of ProtAb in the pathogenesis of DCM...
  11. ncbi Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus
    Jan Broder Engler
    Correspondence to Professor Gabriela Riemekasten, Klinik für Rheumatologie und Klinische Immunologie, Charite Campus Mitte, Chariteplatz 1, 10117 Berlin, Germany
    Ann Rheum Dis 70:2176-83. 2011
    ..The authors assess autoreactive CD4 T cells in a representative SLE collective (n=38) by flow cytometry and study the influence of regulatory T cells (Treg) on their antigenic challenge...
  12. ncbi Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome
    Lars Morawietz
    Department of Rheumatology and Clinical Immunology, Institute of Pathology, and Institute of Biochemistry, Charite Universitatsmedizin Berlin, Free University and Humboldt University of Berlin, Berlin, Germany
    J Rheumatol 36:2694-703. 2009
    ..Minor salivary gland specimens were analyzed to investigate dysregulation of the proteasome system in patients with Sjögren's syndrome (SS) and patients with sicca syndrome...
  13. ncbi Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma
    Christian Jakob
    Department of Hematology and Oncology, Charite Universitatsmedizin Berlin, Germany
    Blood 109:2100-5. 2007
    ..38) survival analysis in patients with active MM. We demonstrate for the first time that increased serum proteasome concentrations correlate with advanced disease and are an independent prognostic factor in MM...
  14. ncbi Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis
    Olga Kordonouri
    Clinics of General Pediatrics, Otto Heubner Centrum für Kinder und Jugendmedizin Charité, Berlin, Germany
    J Pediatr Endocrinol Metab 17:975-81. 2004
    ..In particular, patients with positive thyroid and anti-nuclear antibodies are at high risk to develop autoimmune thyroiditis during the first 5 years of DM1...
  15. ncbi Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients
    Katharina Hanke
    Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin, Humboldt University Berlin, Chariteplatz 1, Berlin 10117, Germany
    Arthritis Res Ther 11:R22. 2009
    ..Furthermore, it remains speculative whether commercially available test systems detecting only anti-PM/Scl-100 antibodies are sufficient in SSc patients...
  16. ncbi Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases
    Karl Egerer
    Department of Rheumatology and Clinical Immunology, Institute of Biochemistry, Humboldt University of Berlin, Berlin, Germany
    J Rheumatol 29:2045-52. 2002
    ..The cProteasomes represent novel sensitive markers of the autoimmune inflammatory processes and/or reflect the magnitude of cellular damage...